Oct 05, 2023
706:695
For every 695 shares held, investors received 706. The price per share adjusted from $40.05 to $39.43.
The split itself did not change the total investment value.
SynCore Biotechnology Co., Ltd. (TPEX:4192) operates in the Pharmaceuticals: major industry.
SynCore Biotechnology Co., Ltd. company overviewSynCore Biotechnology Co., Ltd.'s most recent stock split was on October 5, 2023. It was a 706-for-695 forward split, so shareholders received 706 shares for every 695 they held.
SynCore Biotechnology Co., Ltd. (TPEX:4192) has split its stock 3 times: a 341-for-339 split on August 30, 2016, a 179-for-670 reverse split on July 10, 2023, and a 706-for-695 split on October 5, 2023.
SynCore Biotechnology Co., Ltd. has split its stock 3 times. This history records 3 splits between August 30, 2016 and October 5, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In SynCore Biotechnology Co., Ltd.'s 706-for-695 split on October 5, 2023, every 695 shares became 706 shares.
SynCore Biotechnology Co., Ltd. has not announced a new split in our records. Its most recent split was on October 5, 2023, 3 years ago. Companies announce splits in advance, and any new TPEX:4192 split will appear on this page.
Already premium?